Tumor Lysate Vaccine

BIOLOGICAL2 trials

Sponsors

Masonic Cancer Center, University of Minnesota, Frank Lieberman

Conditions

Diffuse Intrinsic Pontine GliomaHigh Risk WHO Grade II GliomaRecurrent/Post-Chemotherapy WHO Grade II Glioma

Early Phase 1

Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas

CompletedNCT01678352

Frank LiebermanHigh Risk WHO Grade II Glioma, Recurrent/Post-Chemotherapy WHO Grade II Glioma

Start: 2012-10-31End: 2018-11-08Updated: 2020-02-24

Phase 1

Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma

TerminatedNCT01400672

Masonic Cancer Center, University of MinnesotaDiffuse Intrinsic Pontine Glioma

Start: 2012-07-17End: 2018-10-08Updated: 2020-03-18